Elevation Oncology Inc (ELEV)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Shawn M. Leland
Employees:
40
888 SEVENTH AVE, 12TH FLOOR, NEW YORK, NY 10106
212-651-6380

Elevation Oncology focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial.

Data derived from most recent annual or quarterly report
Market Cap 17.523 Million Shares Outstanding24.338 Million Avg 30-day Volume 229.55 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.37
Price to Revenue0.0 Debt to Equity0.4125 EBITDA-85.371 Million
Price to Book Value0.5807 Operating Margin0.0 Enterprise Value-36.236 Million
Current Ratio13.001 EPS Growth-1.514 Quick Ratio12.822
1 Yr BETA 0.3555 52-week High/Low 5.89 / 0.65 Profit Margin0.0
Operating Cash Flow Growth-130.1373 Free Cash Flow to Firm (FCFF) TTM -70.442 Million Free Cash Flow to Equity (FCFE) TTM
Altman Z-Score-3.0358

Are you looking for this stock instead?

View SEC Filings from ELEV instead.

View recent insider trading info

Elevation Oncology Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ELEV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ELEV

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-07-14 by FURLONG TAMMY
  • 3: filed on 2023-07-14 by FURLONG TAMMY
  • 4: filed on 2023-06-21 by WALSH COLIN
  • 4: filed on 2023-06-21 by HU LORI
  • 4: filed on 2023-06-21 by CLACKSON TIMOTHY P
  • 4: filed on 2023-06-21 by CARRUTHERS R MICHAEL
  • 4: filed on 2023-03-20 by FERRA JOSEPH J JR
  • 4: filed on 2023-02-17 by JANSEN VALERIE MALYVANH
  • 4: filed on 2023-02-17 by DORNAN DAVID
  • 4: filed on 2023-02-17 by FERRA JOSEPH J JR

    • Events (8k)

  • 8-K: filed on 2023-08-16:
    Item 8.01: Other Events
  • 8-K: filed on 2023-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-13:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-06-20:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-06-09:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-05:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-17:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    12.6 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    FERRA JOSEPH J JR CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 70,101 2023-09-16 6

    CLACKSON TIMOTHY P

    • Director
    		 47,330 2023-09-01 2

    FURLONG TAMMY CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-07-12 2

    AISLING CAPITAL IV, LP

    AISLING CAPITAL PARTNERS IV LLC

    AISLING CAPITAL PARTNERS IV, LP

    ELMS STEVE

    SCHIFF ANDREW N

    • 10% Owner
    		 0 2023-06-16 1

    CARRUTHERS R MICHAEL

    • Director
    		 0 2023-06-16 1

    HU LORI

    • Director
    		 0 2023-06-16 1

    WALSH COLIN

    • Director
    		 0 2023-06-16 1

    DORNAN DAVID CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2023-02-15 2

    JANSEN VALERIE MALYVANH CHIEF MEDICAL OFFICER

    • Officer
    		 0 2023-02-15 2

    VENBIO GLOBAL STRATEGIC FUND III, L.P.

    VENBIO GLOBAL STRATEGIC GP III, L.P.

    GOODMAN COREY S

    ADELMAN ROBERT J

    ROYSTON AARON

    • 10% Owner
    		 1,905,430 2022-05-25 0

    LELAND SHAWN PRESIDENT, CEO

    • Officer
    • Director
    		 186,500 2022-02-14 0

    CORMORANT ASSET MANAGEMENT, LP

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND III LP

    • 10% Owner
    • FORMER 10% OWNER
    		No longer subject to file 2021-06-29 0

    QIMING U.S. HEALTHCARE FUND II, L.P.

    QIMING U.S. HEALTHCARE GP II, LLC

    • 10% Owner
    		 2,370,142 2021-06-29 0

    VERTEX GLOBAL HC FUND II PTE. LTD.

    • 10% Owner
    		 2,307,642 2021-06-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    FERRA JOSEPH J JR - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-09-19 16:15:17 -0400 2023-09-16 F 4,773 $0.73 d 70,101 direct

    FERRA JOSEPH J JR - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-09-19 16:15:17 -0400 2023-09-16 M 12,562 a 74,874 direct

    FERRA JOSEPH J JR - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-09-19 16:15:17 -0400 2023-09-16 M 12,562 d 87,934 direct

    CLACKSON TIMOTHY P - Director

    		2023-09-05 16:42:04 -0400 2023-09-01 G 15,777 d 0 direct -7.6326 -5.6921 0.0 1 -11.3842 4

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ELEVATION ONCOLOGY INC ELEV 2023-09-21 15:45:04 UTC -4.207 9.527 2000000
    ELEVATION ONCOLOGY INC ELEV 2023-09-21 15:15:03 UTC -4.207 9.527 2000000
    ELEVATION ONCOLOGY INC ELEV 2023-09-21 14:45:04 UTC -4.207 9.527 2000000
    ELEVATION ONCOLOGY INC ELEV 2023-09-21 14:15:04 UTC -4.207 9.527 2000000
    ELEVATION ONCOLOGY INC ELEV 2023-09-21 13:45:04 UTC -3.1373 8.4573 2000000
    ELEVATION ONCOLOGY INC ELEV 2023-09-21 13:15:04 UTC -3.1373 8.4573 2000000
    ELEVATION ONCOLOGY INC ELEV 2023-09-21 12:45:04 UTC -3.1373 8.4573 1800000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 22:15:04 UTC -3.1373 8.4573 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 21:45:04 UTC -3.1373 8.4573 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 21:15:04 UTC -3.1373 8.4573 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 20:45:04 UTC -3.1373 8.4573 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 20:15:05 UTC -3.1373 8.4573 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 19:45:04 UTC -3.1373 8.4573 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 19:15:04 UTC -3.1373 8.4573 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 18:45:04 UTC -3.1373 8.4573 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 18:15:03 UTC -3.1373 8.4573 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 17:45:03 UTC 0.0 0.0 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 17:15:03 UTC 0.0 0.0 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 16:45:03 UTC 0.0 0.0 2200000
    ELEVATION ONCOLOGY INC ELEV 2023-09-20 16:15:03 UTC 0.0 0.0 2200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments